About the Authors
- Alexander Michael Labeit
-
* E-mail: al247@le.ac.uk
Affiliations Clinical Pharmacology Mannheim, Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany, Department of Health Sciences, University of Leicester, Leicester, United Kingdom
- Jens Klotsche
-
Affiliation Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, TU Dresden, Dresden, Germany
- Lars Pieper
-
Affiliation Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, TU Dresden, Dresden, Germany
- David Pittrow
-
Affiliation Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, TU Dresden, Dresden, Germany
- Franziska Einsle
-
Affiliation Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, TU Dresden, Dresden, Germany
- Günter Karl Stalla
-
Affiliation Max Planck Institute of Psychiatry, Munich, Germany
- Hendrik Lehnert
-
Affiliation Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
- Sigmund Silber
-
Affiliation Private Cardiology Practice and Clinic, Munich, Germany
- Andreas Michael Zeiher
-
Affiliation Department of Internal Medicine III, Cardiology, Goethe-University Frankfurt, Frankfurt, Germany
- Winfried März
-
Affiliations Synlab Academy, Synlab Services GmbH, Mannheim, Germany, Mannheim Institute of Public Health, Rupertus Carola University of Heidelberg, Medical Faculty Mannheim, Mannheim, Germany, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
- Martin Wehling
-
Affiliation Clinical Pharmacology Mannheim, Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany
- Hans-Ulrich Wittchen
-
Affiliation Institute of Clinical Psychology and Psychotherapy and Center of Clinical Epidemiology and Longitudinal Studies, TU Dresden, Dresden, Germany
Competing Interests
The authors have read the journal’s policy and have the following conflicts: Alexander Michael Labeit, Jens Klotsche, Lars Pieper, David Pittrow, Franziska Einsle, Günter Karl Stalla, Hendrik Lehnert, Andreas Michael Zeiher, Hans-Ulrich Wittchen: none. Sigmund Silber: The author served as an advisor or consultant for Abbott Laboratories, Boston Scientific, Medtronic. Martin Wehling: The author was employed by AstraZeneca R&D, Mölndal, as director of discovery medicine (translational medicine) from 2003–2006, while on sabbatical leave from his professorship at the University of Heidelberg. After return to this position in January 2007, he receives lecturing and consulting fees from Sanofi-Aventis, Novartis, Takeda, Roche, Pfizer, Bristol-Myers, Daichii-Sankyo, Lilly and Novo-Nordisk. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. Winfried März is affiliated with Synlab Academy, Synlab Services GmbH, Mannheim, Germany, though it has no bearing on this manuscript. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: HL GS AZ WM DP SS MW. Performed the experiments: HL GS AZ WM DP SS MW. Analyzed the data: AL JK LP. Contributed reagents/materials/analysis tools: AL JK LP. Wrote the paper: AL JK LP DP FE GS HL SS AZ WM MW HW.